Abogen has been invited to the 5th Annual mRNA-Based Therapeutics Summit Europe in Berlin, Jan 28-29.

Dr. Bo Ying, CEO of Abogen, will join global industry leaders to explore how to unlock the full potential of mRNA through collectively harnessing scalable design, precision delivery, and validated clinical safety. As an expert speaker, he will present groundbreaking insights on how self-amplifying (saRNA) and circular RNA (circRNA) technologies are overcoming limitations in durability and dosing to create viable therapies for oncology, rare diseases, and beyond.

Abogen's Speaking Session:

Topic: Unlocking the Therapeutic Power of Self-Amplifying & Circular RNA for Longer Expression and Lower Dosing

Date&Time: January 29, 2026, 9:30 AM (CET)

Highlight:

① Discovering how saRNA and circRNA are redefining RNA’s potential with longer lasting expression, lower dosing, and expanded therapeutic applications
② Understanding the scientific and clinical implications of modality-specific challenges, from immunogenicity to delivery complexity
③ Learning from pioneering case studies translating next-generation RNA formats into viable therapies across oncology, rare diseases, and beyond